financetom
Business
financetom
/
Business
/
Exclusive-AstraZeneca pauses $270 million investment in Britain
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exclusive-AstraZeneca pauses $270 million investment in Britain
Sep 12, 2025 10:06 AM

LONDON (Reuters) - Britain's biggest company AstraZeneca ( AZN ) has paused a planned 200 million pound ($271.26 million) investment in its Cambridge research site, a spokesperson said, the latest drugmaker to retreat from Britain.

The decision on the investment, which had been set to create 1,000 jobs, means none of AstraZeneca's ( AZN ) planned new funding - originally announced in March 2024 - is currently proceeding.

In January, the company scrapped plans to invest 450 million pounds in its vaccine manufacturing plant in northern England, citing a cut in British government support.

U.S. drugmaker Merck & Co ( MRK ) this week blamed the UK's challenging business environment as it abandoned a new research centre in London.

Asked about speculation over its pharmaceutical investments following the Merck ( MRK ) announcement, a spokesperson for AstraZeneca ( AZN ), which has the biggest market capitalisation on the FTSE 100, confirmed it would pause its investment plans in Cambridge, where it has one of Britain's leading life sciences hubs.

"We constantly reassess the investment needs of our company and can confirm our expansion in Cambridge is paused. We have no further comment to make," an AstraZeneca ( AZN ) spokesperson said.

The news, which will come as a blow to Prime Minister Keir Starmer's government and its efforts to draw investment into the UK's stagnant economy, comes just days before U.S. President Donald Trump arrives in Britain for a state visit.

AstraZeneca ( AZN ) in July said it would spend $50 billion to expand manufacturing and research capabilities in the United States by 2030 - one of many announcements by pharmaceutical companies reacting to Trump's tariff policy.

Trump has criticised Britain and Europe for not paying high enough prices for drugs, and several pharmaceutical firms have criticised Britain for what they say is long-term undervaluation of medicines and innovation.

After AstraZeneca ( AZN ) dropped its vaccine plant investment plan, Chief Executive Pascal Soriot urged Britain to improve the environment for businesses in order to drive investment.

($1 = 0.7373 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CIBC names new segment chiefs as Canadian banking head moves to vice chair role
CIBC names new segment chiefs as Canadian banking head moves to vice chair role
Sep 6, 2024
TORONTO, Sept 5 (Reuters) - Canadian lender CIBC named Jon Hountalas vice chair of North American banking on Thursday as three other executives take over his current duties as head of Canadian banking, effective Nov. 1. Canada's fifth largest lender had named Chief Financial Officer Hratch Panossian as head of its Canadian personal and business banking unit in April. Hountalas'...
Zeta Global Prices Underwritten Public Offering of Common Shares
Zeta Global Prices Underwritten Public Offering of Common Shares
Sep 6, 2024
06:31 AM EDT, 09/05/2024 (MT Newswires) -- Zeta Global Holdings ( ZETA ) said late Wednesday it has priced an underwritten public offering of 13.2 million class A common shares at $23.50 per share for gross proceeds of about $204.9 million. The company is offering about 8.7 million of its shares, while selling stockholder GPI Capital Gemini is offering about...
Apollo Enters Deal to Acquire Dutch Equipment Leasing Business Beequip
Apollo Enters Deal to Acquire Dutch Equipment Leasing Business Beequip
Sep 6, 2024
06:30 AM EDT, 09/05/2024 (MT Newswires) -- Apollo (APO) said Thursday it has agreed to acquire equipment leasing company Beequip from NIBC. Netherlands-based Beequip has a current portfolio of 1.4 billion euros ($1.55 billion) and 700 million euros annual run-rate originations, Apollo said. The deal is expected to close before year-end 2024, subject to customary closing conditions. Terms of the...
Update: Robinhood Crypto Makes $3.9 Million Settlement in California AG Case
Update: Robinhood Crypto Makes $3.9 Million Settlement in California AG Case
Sep 6, 2024
06:31 AM EDT, 09/05/2024 (MT Newswires) -- (Updates with Robinhood's comment in the last paragraph.) California Attorney General Rob Bonta said Wednesday it has reached a $3.9 million settlement with Robinhood's (HOOD) cryptocurrency division for not letting customers withdraw their digital assets from their accounts from 2018 to 2022, and for not disclosing details of its trading and order handling...
Copyright 2023-2026 - www.financetom.com All Rights Reserved